半岛bd体育手机客户端 说明
生化/生理作用
NIDA-41020 is a CB1 cannabinoid receptor antagonist. NIDA-41020 is structurally similar to Rimonabant, which is currently in clinical development. NIDA-41020 is less lipophilic; developed at NIDA as a potential radioligand for CB1receptors, Ki= 4.1 nM [in comparison AM 251, AM 281, SR 141716 (Rimonabant) have Kiof 0.6, 4.5 and 1.8 nM respectively].
基本信息
| 经验(实验)分子式 | C23H24Cl2N4O2 |
| 分子量 | 459.37 |
| MDL编号 | MFCD08277026 |
| PubChem化学物质编号 | 329818682 |
| NACRES | NA.77 |
半岛bd体育手机客户端 性质
| 质量水平 | 100 |
| 测定 | ≥97% (HPLC) |
| 形式 | solid |
| 颜色 | off-white |
| 溶解性 | DMSO: ~16 mg/mL H2O: insoluble |
| 储存温度 | 2-8℃ |
| SMILES string | COc1ccc(cc1)-c2c(C)c(nn2-c3ccc(Cl)cc3Cl)C(=O)NN4CCCCC4 |
| InChI | 1S/C23H24Cl2N4O2/c1-15-21(23(30)27-28-12-4-3-5-13-28)26-29(20-11-8-17(24)14-19(20)25)22(15)16-6-9-18(31-2)10-7-16/h6-11,14H,3-5,12-13H2,1-2H3,(H,27,30) |
| InChI key | KWDBQJRWPWTGPF-UHFFFAOYSA-N |
安全信息
| 象形图 |  |
| 警示用语： | Danger |
| 危险声明 | H300 - H315 - H319 - H335 |
| 预防措施声明 | P261 - P264 - P270 - P301 + P310 - P302 + P352 - P305 + P351 + P338 |
| 危险分类 | Acute Tox. 2 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| 靶器官 | Respiratory system |
| 储存分类代码 | 6.1A - Combustible, acute toxic Cat. 1 and 2 / very toxic hazardous materials |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
| 个人防护装备 | Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges |
Sigma-Aldrich
m.cnreagent.com
